| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2008 | CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: use of CAS for high-sensitivity anticancer drug screening. | Liao, CF; Luo, SF; Tsai, CS; Tsao, TY; Chen, SL; Jiang, MC. | Toxicol. Mech. Method. 18, 771-776 | | | |
| 2010 | Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium | Uen, WC; Tai, CJ; Shen, SC; Lee, WR; Tsao, TY; Deng, WP; Chiou, HY; Hsu, CH; Hsieh, CI; Liao, CF; Jiang, MC | J Mol Histol. 41(4-5), 259-266 | | | |
| 2009 | Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. | Tsao, TY; Tsai, CS; Tung, JN; Chen, SL; Yue, CH; Liao, CF; Wang, CC; Jiang, MC | Molecular and cellular biochemistry 327(1-2), 163-170 | | | |
| 2009 | Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. | Tung, MC; Tsai, CS; Tung, JN; Tsao, TY; Chen, HC; Yeh, KT; Liao, CF; Jiang, MC | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 18(5), 1570-1577 | | | |
| 2010 | Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer | Tsai, CS; Chen, HC; Tung, JN; Tsou, SS; Tsao, TY; Liao, CF; Chen, YC; Yeh, CY; Yeh, KT; Jiang, MC | Am J Pathol. 176(4),1619-28 | | | |
